1 / 7

Contract Research Organization (CRO) Market_PPT

The contract research organization (CRO) market is poised to record significant proceeds through the ensuing years, due to a rise in research and development expenditure at the global level. The highest R&D expenses are registered in the biopharmaceutical and pharmaceutical industries.<br><br>Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/3012

11788
Download Presentation

Contract Research Organization (CRO) Market_PPT

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Contract Research Organization (CRO) Market is projected to reach CAGR 7.8% by 2027

  2. Key Insights from Contract Research Organization (CRO) Market: • The contract research organization (CRO) industry is poised to record significant proceeds through the ensuing years, due to a rise in research and development expenditure at the global level. The highest R&D expenses are registered in the biopharmaceutical and pharmaceutical industries. • The contract research organization (CRO) market is further driven by an increase in investments in research and development activities in the areas of gastroenterology & hepatology. The segment is set to record a value of USD 3 billion of the overall market share by 2027. • This revenue is attributed to the rising focus of various types of contract research organizations on clinical trial development in the sector of gastroenterology & hepatology. Increasing incidences of chronic hepatology disorders comprising cirrhosis and hepatitis-A at the global level are expected to augment the new drug development process for the treatment of these disorders, bolstering contract research organization (CRO) industry outlook through the forecasted period.

  3. Regional Insights in Contract Research Organization (CRO) Market: • Speaking of which, there is a considerable rise in number of clinical trials as well as R&D initiatives, emergence of severe diseases, and a huge patient pool in Asia Pacific. In fact, the regional contract research organization market size is estimated to grow at a substantial CAGR of 9.1% between 2021 and 2027. • In addition, governments of numerous countries in the Asia Pacific are showing a keen interest in the provision of funding for drug discovery and associated research studies. Further, the region has also recorded a remarkable shift in biotechnology firms, which has been instrumental in impelling the growth of contract research organization (CRO) industry. • To add on, amid the COVID-19 pandemic, a spike in the number of SARS-CoV-2 cases has been responsible for attracting CROs for conducting trials to fast-track procedures and take advantage of the huge patient population, thereby propelling Asia Pacific CRO market growth through 2027.

  4. Latest Research Report On Contract Research Organization (CRO) Market@ https://www.gminsights.com/industry-analysis/contract-research-organization-cro-market Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/3012

  5. Major Companies in Contract Research Organization (CRO) Market: • Laboratory Corporation of America Holdings • IQVIA • Pharmaceutical Product Development • PRA Health Science • PAREXEL International • Syneos Health

  6. Industry Coverage

  7. Stay In Touch Website: www.gminsights.com Social Media:

More Related